R1 RCM (RCM) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
3 Feb, 2026Technology Platform and Data Ecosystem
Unmatched breadth and depth of healthcare data, covering over 550 million patient encounters annually and 60% of the acute care market, with over 95% payer connectivity.
Deep integration into customer workflows enables precise automation and actionable insights at critical points.
Proprietary knowledge, best practices, and workflow orchestration are embedded in standard operating procedures, rules, and algorithms.
Cloudmed acquisition enhanced data scale and machine learning capabilities, now fully integrated into the platform.
Migration to Microsoft Azure Cloud completed on time and under budget, improving scalability, cost control, resiliency, and cybersecurity, with ~2 petabytes of data migrated.
AI, Automation, and Innovation
Automation-first, AI-enabled platform automates over 200 million tasks annually, impacting work equivalent to 5,000+ FTEs, with ongoing expansion using RPA, machine learning, and generative AI.
AI-driven solutions include automated clinical appeals, physician coding quality assurance, and call quality insights, with recent applications reducing clinical appeal creation time by 75% and enabling 100% QA of calls.
AI and automation are deployed incrementally, with a four-phase approach from human-in-the-loop to full autonomy.
Generative AI is used to streamline complex processes like prior authorizations and clinical appeals, reducing manual effort, increasing accuracy, and expected to reduce costs by 40%.
Continuous feedback loops from user interactions drive ongoing process and technology improvements.
New Modular Solutions and Client Impact
Insurance Discovery solution increases annual recoveries by over 10% compared to competitors, leveraging proprietary data and automation.
Modular Coding relieves staffing constraints, improves capacity by 2-3x, and reduces charging lag by ~30%.
Patient Receivables solution improves patient payments by up to 10% and achieves over 90% patient satisfaction.
New solutions are designed to be scalable and reusable across multiple business lines, accelerating cash collection and improving patient satisfaction.
Return on investment for new initiatives averages less than 24 months, with rapid deployment and iteration.
Latest events from R1 RCM
- 12% revenue growth, $7.6M net loss, and $14.30/share buyout expected to close by year-end.RCM
Q2 20242 Feb 2026 - Strong Q1, resilient growth, and strategic integration drive outlook despite cyber disruptions.RCM
Jefferies Global Healthcare Conference1 Feb 2026 - Q3 revenue up 15% but net loss of $19.9M due to higher costs and cyberattack impacts.RCM
Q3 202413 Jun 2025